Clinical Trials Logo

Clinical Trial Summary

The present study will investigate the long term effect of allergen immunotherapy in a real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy with grass pollen, birch, house dust mites or venom.


Clinical Trial Description

The study will include children aged 5- 18 years who are treated with immunotherapy at Hans Christian Andersen Children' Hospital, Odense University Hospital. Informed consent to be registered in a database and to receive a questionnaire 5 and 10 years after end of treatment are obtained before start of immunotherapy. Base line data include information from the patient record: symptoms, medication, blood test and skin prick test results. During treatment effect, medication use, lung function and adverse events are monitored systematically once a year. The questionnaires 5 and 10 years after end of treatment will focus on allergy symptoms, use of medication and asthma symptoms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06421415
Study type Observational [Patient Registry]
Source Odense University Hospital
Contact Josefine Gradman, PhD
Phone 0045 29241375
Email josefine.gradman@rsyd.dk
Status Recruiting
Phase
Start date May 1, 2024
Completion date May 1, 2037

See also
  Status Clinical Trial Phase
Recruiting NCT04331522 - Allergen Provocations- HCA Children's Hospital
Active, not recruiting NCT03225534 - Project 500 CHILD Study N/A